Victoria Villaflor, MD, board-certified UCI Health medical oncologist who specializes in cancers of the head and neck, shared promising early results at ASCO 2026 for a new treatment approach in head and neck cancer.

Her study tested a targeted therapy designed specifically for patients whose tumors express a specific protein marker often linked to less than favorable outcomes. What makes this data particularly encouraging is that it showed positive responses even in patients who had already gone through multiple prior treatments, a group that typically struggles to find effective options.